275 related articles for article (PubMed ID: 16493490)
41. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
[TBL] [Abstract][Full Text] [Related]
42. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
43. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the cutoff values in fibrin-related markers for the diagnosis of overt DIC.
Hatada T; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Imai H; Kaneko T; Nobori T;
Clin Appl Thromb Hemost; 2012 Sep; 18(5):495-500. PubMed ID: 22203032
[TBL] [Abstract][Full Text] [Related]
45. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
Madoiwa S
Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
[No Abstract] [Full Text] [Related]
46. Disseminated intravascular coagulation (DIC).
Mammen EF
Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
[TBL] [Abstract][Full Text] [Related]
47. [Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
Iwabuchi S; Takatori M; Okabe K
Nihon Rinsho; 1993 Jan; 51(1):67-73. PubMed ID: 8381886
[TBL] [Abstract][Full Text] [Related]
48. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy.
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):60-4. PubMed ID: 7540878
[TBL] [Abstract][Full Text] [Related]
49. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
50. An Evaluation of the Modified Diagnostic Criteria for DIC Established by the Japanese Society of Thrombosis and Hemostasis.
Aota T; Wada H; Yamashita Y; Matsumoto T; Ohishi K; Suzuki K; Imai H; Usui M; Isaji S; Asakura H; Okamoto K; Katayama N
Clin Appl Thromb Hemost; 2017 Sep; 23(6):579-584. PubMed ID: 27301403
[TBL] [Abstract][Full Text] [Related]
51. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].
Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H
Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641
[TBL] [Abstract][Full Text] [Related]
52. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
54. Can advanced hemostatic parameters detect disseminated intravascular coagulation more accurately in patients with cirrhosis of the liver?
Ho CH; Hou MC; Lin HC; Lee SD; Liu SM
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jun; 61(6):332-8. PubMed ID: 9684509
[TBL] [Abstract][Full Text] [Related]
55. Hypercoagulability and DIC in high-risk infants.
Suzuki S; Morishita S
Semin Thromb Hemost; 1998; 24(5):463-6. PubMed ID: 9834014
[TBL] [Abstract][Full Text] [Related]
56. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation.
Lehman CM; Wilson LW; Rodgers GM
Am J Clin Pathol; 2004 Aug; 122(2):178-84. PubMed ID: 15323133
[TBL] [Abstract][Full Text] [Related]
57. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
58. Hypercoagulation and hypofibrinolysis in horses with colic and DIC.
Monreal L; Anglés A; Espada Y; Monasterio J; Monreal M
Equine Vet J Suppl; 2000 Jun; (32):19-25. PubMed ID: 11202377
[TBL] [Abstract][Full Text] [Related]
59. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
[TBL] [Abstract][Full Text] [Related]
60. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
